NL-OMON21569招募中不适用
Risk-group Infant Vaccination Agains RotavirusImplementation and Phase IV Effectiveness study
MC UtrechtHeidelberglaan 1003508 GA UtrechtThe Netherlands0 个研究点目标入组 2,000 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Infants 6 weeks 0 days to 13 weeks 6 days of age who receive medical care in hospital or through outpatient clinics at the time of the first vaccine dose administration in one of the participating hospitals and
- •2. Diagnosed with at least one high-risk condition:
排除标准
- •Known hypersensitivity to any of the vaccine components.
- •Previous intussusception or an uncorrected congenital condition predisposing to intussusception (such as Meckel’s diverticle).
研究者
相似试验
已完成
不适用
Safety and efficacy of rotavirus vaccine in infants admitting NICU; comparison between RV1 and RV5.Infants in NICJPRN-UMIN000016458Fujita Health University School of Medicine. Dept. of Pediatrics40
进行中（未招募）
不适用
To study the effectiveness and safety of Rotasiil vaccine in JharkhandCTRI/2019/02/017825PATH1,422
已完成
不适用
Vaccine Effectiveness of RV1 in a Naïve PopulationRotavirus InfectionsDiarrheaGastroenteritisNCT01467037McGill University Health Centre/Research Institute of the McGill University Health Centre374
已完成
1 期
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel SyndromeShort Bowel SyndromeNCT00767364Children's Hospital of Michigan8
进行中（未招募）
1 期
‘Premature infants and maternal pertussis immunization. Is second trimester vaccination beneficial?women in their first trimester of pregnancyEUCTR2018-002976-41-NLRIVM120